Table 5.
Summary of Analysis of Adverse Events in All Subjects
| |
|
Severity |
|
|
||
|---|---|---|---|---|---|---|
| Number of AEs | Mild | Moderate | Severe | Subjects reporting AEs | Treatment related | |
| Placebo | 5 | 5 | 0 | 0 | 5 | None |
| Meratrim | 5 | 5 | 0 | 0 | 4 | None |
Common adverse events (AEs) reported were headache, nausea, gastrointestinal irritation, general weakness, back, leg, ankle, and joint pain.